Nairobi is aiming to open a new medical oxygen production facility in the first quarter of 2025.
The facility is earmarked for the Tatu Industrial Zone within the 5,000-acre Tatu City Special Economic Zone.
Leading locally owned medical oxygen manufacturer Hewatele has secured $20 million funding from the US International Development Finance Corporation, Finnfund, Soros Economic Development Fund (SEDF), UBS Optimum Foundation and Grand Challenges Canada.
Hewatele will use the debt and equity funds raised to finance the building of a modern Cryogenic Medical Liquid Oxygen Air Separation Unit plant at the industrial park.
... to continue reading you must be subscribed
